The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back. (Q46452341)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

The interpretation of glucose clamp studies of long-acting insulin analogues: from physiology to marketing and back (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

S G H A Swinnen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

F Holleman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

language of work or name

1 reference

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

1790-1795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18670752%20AND%20SRC:MED&resulttype=core&format=json

Comparison of Pharmacokinetics and Dynamics of the Long-Acting Insulin Analogs Glargine and Detemir at Steady State in Type 1 Diabetes: A double-blind, randomized, crossover study

11 January 2020

cites work

1 reference

12 December 2020

Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo

1 reference

12 December 2020

Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes

1 reference

12 December 2020

Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique

1 reference

12 December 2020

Time-action profile of the long-acting insulin analogue insulin glargine in comparison to NPH insulin in Japanese volunteers.

1 reference

12 December 2020

Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes

1 reference

12 December 2020

A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

1 reference

12 December 2020

Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus

1 reference

12 December 2020

Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart

1 reference

12 December 2020

Nice insulins, pity about the evidence

1 reference

12 December 2020

Measurement of insulin absorption and insulin action

1 reference

12 December 2020

Antegrade intravenous catheterization for metabolic studies in man.

1 reference

12 December 2020

Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes

1 reference

12 December 2020

Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

1 reference

12 December 2020

Optimal timing of injection of once-daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal-times

1 reference

12 December 2020

To: Scholtz HE, Pretorius SG, Wessels DH, Becker RHA (2005) Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique. Diabetologia 48:1

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of the long-acting insulin analog glargine after 1 week of use compared with its first administration in subjects with type 1 diabetes

1 reference

12 December 2020

Glucose clamp technique: a method for quantifying insulin secretion and resistance

1 reference

12 December 2020

Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes

1 reference

12 December 2020